Zentek Ltd.

NASDAQ:ZTEK

Other Precious Metals

Basic Materials
$0.49 +25.56%

+$0.10 today

Market cap
$62.30M
Beta
0.47
P/E (TTM)
-9.6
EPS (TTM)
-$0.08
52W Low $0.37High $1.34

Volume 0.93M

Average 0.15M

ZTEK Operating Income

Profit from core operations after operating expenses, before interest and taxes.

Zentek Ltd.NASDAQ: ZTEK

Operating Income · Q4 FY2025 · quarter ended Mar 2026

Operating income remains negative

Q4 FY2025 operating income was -CA$3.85M, compared with -CA$2.1M a year earlier. Trailing-twelve-month operating income was -CA$10.51M.

Context

  • Operating income amounted to 6521.7% of revenue in FY2025, up 5421.3 pp from a year earlier.
  • Operating income grew in size in 1 of the last 3 fiscal years.

What to watch

Whether operating income reaches the consensus estimate from 1 analysts of -CA$4.35M (+59.9%) for the fiscal year ending Mar 2027, a step up from the -13.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$3.85M-39.2% QoQ
Last fiscal yearMar 2026
-CA$10.86M-13.1% YoY
LTMMar 2026
-CA$10.51M-9.4% YoY
Operating Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-83.6%-113.0%-29.5 pp
1 year-13.1%+59.9%+73.0 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Income history

CAD · from the income statement

Latest · FY2025
(10.86M) CAD
Year-over-year change
-13.1%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Income vs competitors

How ZTEK compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -9.4% is the 7th highest of 9, against a peer median of +12.0%.
  • Operating income amounts to 6325.9% of revenue for ZTEK, versus a peer median of 146.0%.
ZTEK Competitors
Operating Income for ZTEK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BYSIBeyondSpring Inc.LTM Mar 2026-$8.57M USD-11.9%——
ZTEKZentek Ltd.LTM Mar 2026-CA$10.51M CAD-9.4%—6325.9%
HYFTMindWalk Holdings Corp.LTM Jan 2026-CA$11.99M CAD+23.1%—65.3%
MBOTMicrobot Medical Inc.LTM Mar 2026-$16.04M USD-30.8%—15278.1%
HYPRHyperfine, Inc.LTM Mar 2026-$34.74M USD+20.1%—226.6%
CRDLCardiol Therapeutics Inc.LTM Mar 2026-CA$35.62M CAD-1.3%——
AMWLAmerican Well CorporationLTM Mar 2026-$87.81M USD+49.2%—37.0%
ALXOALX Oncology Holdings Inc.LTM Mar 2026-$91.17M USD+33.2%——
GUTSFractyl Health, Inc. Common StockLTM Mar 2026-$92.88M USD+4.0%——
Peer median (excluding ZTEK) —+12.0%—146.0%

Competitors are the stored peer set for ZTEK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Revenue339.67K72.86K29.82K872.5K166.48K
Cost of Revenue376.79K853.34K331.08K680.01K6.47M
Gross Profit(37.12K)(780.48K)(301.26K)192.49K(6.3M)
Gross Margin-10.9%-1071.3%-1010.4%22.1%-3785.5%
Research & Development1.54M1.65M1.78M465.65K1.66M
Selling, General & Admin9.56M10.99M8.95M8.01M2.87M
Operating Expenses12.53M13.87M11.68M9.79M4.56M
Depreciation & Amortization614.71K539.69K613.71K600.32K527.77K
EBITDA(31.02M)(13.75M)(11.08M)(9.35M)(10.33M)
EBITDA Margin-9131.2%-18878.5%-37170.3%-1071.4%-6204.7%
Operating Income(12.56M)(14.65M)(11.98M)(9.6M)(10.86M)
Operating Margin-3698.5%-20112.5%-40174.8%-1100.4%-6521.7%
Interest Income20.6K510.26K405.48K101.61K40.41K
Interest Expense63.78K120.62K107.37K91.32K289.98K
Other Income / Expenses(19.13M)238.68K174.74K(439.03K)1.06M
Income Before Tax(31.69M)(14.41M)(11.8M)(10.04M)(9.79M)
Pre-Tax Margin-9330.9%-19784.9%-39588.7%-1150.7%-5882.6%
Income Tax Expense00(99.78K)00
Net Income(31.69M)(14.41M)(11.7M)(10.04M)(9.79M)
Net Margin-9330.9%-19784.9%-39254.1%-1150.7%-5882.6%
EPS (Basic)(0.42)(0.14)(0.12)(0.10)(0.09)
EPS (Diluted)(0.42)(0.14)(0.12)(0.10)(0.09)
Weighted Avg Shares92.09M99.44M97.53M102.98M105.92M
Weighted Avg Shares (Diluted)92.09M99.44M100.5M102.98M105.92M

Zentek Ltd.

NASDAQ:ZTEK

Intrinsic Alpha fair value

Locked

Current Price

$0.49

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.